On October 9, 2023, Zencore Biologics Co., Ltd. (referred to as "Zencore Biologics") and Glyco-therapy Biotechnology Co., Ltd. (referred to as " Glyco-therapy Biotechnology") signed a strategic cooperation agreement in the field of ADC drug glycan-targeted conjugate drug research and production. Both parties will jointly strive to build a comprehensive resource collaboration and service platform for the development of next-generation ADC drugs, providing diversified, high-quality, and efficient support throughout the entire process, from early-stage ADC drug discovery to clinical pharmacological research and commercial production.
